Literature DB >> 1308840

Cutaneous squamous cell carcinoma in Tanzania.

H Amir1, M P Mbonde, J N Kitinya.   

Abstract

The Tanzania Cancer Registry at Muhimbili Medical Centre, Dar es Salaam, Tanzania was reviewed for squamous cell carcinoma of the skin in non-albino African subjects. The data was analysed for age, sex, site and predisposing factors. Our results were then compared with studies previously carried out in Tanzania, elsewhere in Africa and also on Blacks in America. Squamous cell carcinoma of the skin was found to be a common malignancy, and the commonest skin cancer. Its peak was in the 40-49 years age group though it could occur in children under five years of age. The most affected site was the lower limb, followed by the head and the neck. The penis in the male and the vulva in the female were the third most affected sites. The scalp and the lip were more affected in females than males. Chronic trauma, chronic ulcers, and scars were the main predisposing risk factors to the lower limb and the scalp, while ultra violet radiation to the head and neck, and smegma of the uncircumcised penis were thought to be predisposing risk factors.

Entities:  

Mesh:

Year:  1992        PMID: 1308840

Source DB:  PubMed          Journal:  Cent Afr J Med        ISSN: 0008-9176


  4 in total

Review 1.  Marjolin's ulcers in sub-Saharan Africa.

Authors:  Peter M Nthumba
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

Review 3.  Racial and Ethnic Healthcare Disparities in Skin Cancer in the United States: A Review of Existing Inequities, Contributing Factors, and Potential Solutions.

Authors:  Kimberly Shao; Hao Feng
Journal:  J Clin Aesthet Dermatol       Date:  2022-07

4.  Report from the second MIB (Melanoma Independent Board) Conference, 27-28 October 2014.

Authors:  Alessandro Testori; Carlo Riccardo Rossi; Paolo Ascierto; Francesco de Lorenzo; Nicola Mozzillo
Journal:  Ecancermedicalscience       Date:  2015-02-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.